Drawing for MEDFACE

USPTO serial 86472841

MEDFACE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDFACE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander JSW Johnson

ALEXANDER JSW JOHNSON HAMILTON IP LAW, PC2322 E Kimberly Rd235WDAVENPORT, IA 52807

Goods and services

ClassDescriptionStatusFirst use
042Technical support services, namely, troubleshooting in the nature of diagnosing problems with medical technology used for facial feature recognition and analysis; Maintenance of computer software used for facial feature analysis, recognition, tracking, and recording devices; Maintenance and updating of computer software; Maintenance and upgrading of computer software; Maintenance of computer software; Platform as a service (PAAS) featuring computer software platforms for use in provision of medical services; Platform as a service (PAAS) featuring computer software platforms for use with devices used for facial feature analysis, recognition, tracking, and recording; Platform as a service (PAAS) featuring computer software platforms for use in medical diagnosis, evaluation, monitoring, reporting, and consultation services; Platform as a service (PAAS) featuring computer software platforms for use in medical diagnosis, evaluation, monitoring, and consultation services; Platform as a service (PAAS) featuring computer software platforms for use in medical consultation services; Platform as a service (PAAS) featuring computer software platforms for use in medical diagnosis services; Platform as a service (PAAS) featuring computer software platforms for use in medical evaluation services; Platform as a service (PAAS) featuring computer software platforms for use in medical monitoring services; Platform as a service (PAAS) featuring computer software platforms for use with devices for facial feature analysis, recognition, tracking, and recording for the purpose of providing medical services; Platform as a service (PAAS) featuring computer software platforms for use in providing diagnostic, screening, and other medical services by medical and health professionals; Platform as a service (PAAS) featuring computer software platforms for use in providing diagnostic, screening, and other medical services by medical professionals; Platform as a service (PAAS) featuring computer software platforms for use in providing diagnostic, screening, and other medical services by health professionals; Platform as a service (PAAS) featuring computer software platforms for use with electromyography and vibrometry devices used for facial feature analysis, recognition, tracking, and recording; Platform as a service (PAAS) featuring computer software platforms for use with electromyography devices used for facial feature analysis, recognition, tracking, and recording; Platform as a service (PAAS) featuring computer software platforms for use with vibrometry devices used for facial feature analysis, recognition, tracking, and recording; Software as a service (SAAS) featuring software for use in provision of medical services; Software as a service (SAAS) featuring software for use with devices used for facial feature analysis, recognition, tracking, and recording; Software as a service (SAAS) featuring software for use in medical diagnosis, evaluation, monitoring, reporting, and consultation services; Software as a service (SAAS) featuring software for use in medical diagnosis, evaluation, monitoring, and consultation services; Software as a service (SAAS) featuring software for use in medical consultation services; Software as a service (SAAS) featuring software for use in medical diagnosis services; Software as a service (SAAS) featuring software for use in medical evaluation services; Software as a service (SAAS) featuring software for use in medical monitoring services; Software as a service (SAAS) featuring software for use in facial feature analysis, recognition, tracking, and recording for the purpose of providing medical services; Software as a service (SAAS) featuring software for use with facial feature analysis, recognition, tracking, and recording systems; Software as a service (SAAS) featuring software for use with facial feature analysis, recognition, tracking, and recording technologies; Software as a service (SAAS) featuring software for use with facial feature analysis, recognition, tracking, and recording devices; Software as a service (SAAS) featuring software for facial feature analysis, recognition, tracking, and recording via infrared camera and infrared flash recordings; Software as a service (SAAS) featuring software for use by medical and health professionals in providing diagnostic, screening, and other medical services; Software as a service (SAAS) featuring software for use by medical professionals in providing diagnostic, screening, and other medical services; Software as a service (SAAS) featuring software for use by healthcare professionals in providing diagnostic, screening, and other medical services; Software as a service (SAAS) featuring software for use with electromyography and vibrometry devices used for facial feature analysis, recognition, tracking, and recording; Software as a service (SAAS) featuring software for use with electromyography devices used for facial feature analysis, recognition, tracking, and recording; Software as a service (SAAS) featuring software for use with vibrometry devices used for facial feature analysis, recognition, tracking, and recordingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 13, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 13, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 10, 2018EX5GSOU EXTENSION 5 GRANTED—
Jan 4, 2018EXT5SOU EXTENSION 5 FILED—
Jan 4, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 27, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 6, 2017EX4GSOU EXTENSION 4 GRANTED—
Jul 6, 2017EXT4SOU EXTENSION 4 FILED—
Jul 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 6, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2017EX3GSOU EXTENSION 3 GRANTED—
Jan 6, 2017EXT3SOU EXTENSION 3 FILED—
Jan 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 9, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 8, 2016EX2GSOU EXTENSION 2 GRANTED—
Aug 5, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 7, 2016EXT2SOU EXTENSION 2 FILED—
Jul 7, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 5, 2016EXT1SOU EXTENSION 1 FILED—
Jan 5, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 12, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2015DOCKASSIGNED TO EXAMINER—
Dec 12, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Dec 11, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance